IN2012DN00758A - - Google Patents

Download PDF

Info

Publication number: IN2012DN00758A
Authority: IN; India
Prior art keywords: salt; general formula; phenyl group; relates; present
Prior art date: 2005-05-13

Application number

Other languages

English (en)

Inventor

Kurimura Muneaki

Taira Shinichi

Tomoyasu Takahiro

Ito Nobuaki

Tai Kuninori

Takemura Noriaki

Matsuzaki Takayuki

Menjo Yasuhiro

Miyamura Shin

Sakurai Yohji

Watanabe Akihito

Sakata Yasuyo

Masumoto Takumi

Akazawa Kohei

Sugino Haruhiko

Amada Naoki

Ohashi Satoshi

Shinohara Tomoichi

Sasaki Hirofumi

Morita Chisako

Yamashita Junko

Nakajima Satoko

Original Assignee

Otsuka Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-05-13

Filing date

2006-05-12

Publication date

2015-06-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36693623&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN00758(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-05-12 Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd

2015-06-19 Publication of IN2012DN00758A publication Critical patent/IN2012DN00758A/en

Links

RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Natural products C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
-1 pyrrolidine compound Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Addiction (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychology (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Pregnancy & Childbirth (AREA)
Child & Adolescent Psychology (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IN758DEN2012 2005-05-13 2006-05-12 IN2012DN00758A (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2005141230		2005-05-13
PCT/JP2006/309988 WO2006121218A1 (en)	2005-05-13	2006-05-12	N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors

Publications (1)

Publication Number	Publication Date
IN2012DN00758A true IN2012DN00758A (pl)	2015-06-19

Family

ID=36693623

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN758DEN2012 IN2012DN00758A (pl)	2005-05-13	2006-05-12

Country Status (24)

Country	Link
US (6)	US8084442B2 (pl)
EP (2)	EP2407451B1 (pl)
JP (1)	JP4776631B2 (pl)
KR (2)	KR100971850B1 (pl)
CN (3)	CN103613587A (pl)
AR (1)	AR054191A1 (pl)
AU (2)	AU2006244851B2 (pl)
BR (1)	BRPI0610279A2 (pl)
CA (1)	CA2608184C (pl)
CY (1)	CY1114767T1 (pl)
DK (1)	DK2407451T3 (pl)
ES (2)	ES2451523T3 (pl)
IL (1)	IL187311A (pl)
IN (1)	IN2012DN00758A (pl)
MX (1)	MX2007014252A (pl)
MY (1)	MY148653A (pl)
PL (1)	PL2407451T3 (pl)
PT (1)	PT2407451E (pl)
RU (1)	RU2414454C2 (pl)
SG (1)	SG162722A1 (pl)
SI (1)	SI2407451T1 (pl)
TW (3)	TWI410406B (pl)
WO (1)	WO2006121218A1 (pl)
ZA (1)	ZA200709691B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004050024A2 (en)	2002-11-27	2004-06-17	Incyte Corporation	3-aminopyrrolidine derivatives as modulators of chemokine receptors
TWI410406B (zh)	2005-05-13	2013-10-01	Otsuka Pharma Co Ltd	吡咯烷化合物
BRPI0619263A2 (pt) *	2005-11-30	2011-09-27	Hoffmann La Roche	indóis de 3-amino-1-arilpropila e indóis aza-substituìdos, métodos para prepará-los, composição farmacêutica e uso dos referidos indóis
WO2007065093A2 (en) *	2005-11-30	2007-06-07	Smithkline Beecham Corporation	Pyrrolidineanilines
JP5219465B2 (ja) *	2006-11-10	2013-06-26	大塚製薬株式会社	医薬
BRPI0909737A2 (pt) *	2008-03-20	2019-03-06	F. Hoffmann-La Roche Ag	compostos de pirrolidinila, composição farmacêutica compreendendo os mesmos e usos dos mesmos
WO2011054433A1 (en)	2009-11-07	2011-05-12	Merck Patent Gmbh	Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors
US8541596B2 (en) *	2010-04-21	2013-09-24	Probiodrug Ag	Inhibitors
CN102766079B (zh) *	2011-05-06	2015-04-08	上海医药工业研究院	一类吡咯烷衍生物、其制备方法及应用
WO2015050984A1 (en)	2013-10-01	2015-04-09	New York University	Amino, amido, and heterocyclic compounds as modulators of rage activity and uses thereof
KR20160148871A (ko)	2015-06-17	2016-12-27	양순구	일방향 클러치 제동장치
WO2017070796A1 (en) *	2015-10-30	2017-05-04	Trillium Therapeutics Inc.	Heterocycle derivatives and their use for the treatment of cns disorders
EP3846793B1 (en)	2018-09-07	2024-01-24	PIC Therapeutics, Inc.	Eif4e inhibitors and uses thereof
RU2698400C1 (ru) *	2018-12-17	2019-08-26	Георгий Сергеевич Немов	Способ лечения депрессии у собак и кошек
CN113024518A (zh) *	2019-12-09	2021-06-25	武汉九州钰民医药科技有限公司	一种厄达替尼的制备方法
CN113024517A (zh) *	2019-12-09	2021-06-25	武汉九州钰民医药科技有限公司	一种制备厄达替尼的方法
AR121506A1 (es)	2020-03-03	2022-06-08	Pic Therapeutics Inc	Inhibidores del eif4e y sus usos
IL310924A (en)	2021-08-25	2024-04-01	Pic Therapeutics Inc	Eif4e inhibitors and uses thereof
US12157732B2 (en)	2021-08-25	2024-12-03	PIC Therapeutics, Inc.	eIF4E inhibitors and uses thereof
WO2024168426A1 (en) *	2023-02-13	2024-08-22	Apogee Pharmaceuticals, Inc.	Small molecules as monoacylglycerol lipase (magl) inhibitors, compositions and use thereof
WO2025030117A1 (en) *	2023-08-02	2025-02-06	Arpeggio Biosciences, Inc.	Ferroptosis inducers

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1164828A (en)	1965-10-23	1969-09-24	Robins Co Inc A H	3-(2-Substituted Ethyl)Indoles and their Manufacture and Use
GB1173373A (en) *	1966-03-22	1969-12-10	Robins Co Inc A H	Substituted 3-Aminopyrrolidines
US3509171A (en)	1967-09-14	1970-04-28	Robins Co Inc A H	3-amino-1-carbamyl and thiocarbamyl pyrrolidines
US3433802A (en)	1968-06-25	1969-03-18	Robins Co Inc A H	3-(n-lower-alkylanilino)pyrrolidines
US3577440A (en)	1968-12-23	1971-05-04	Robins Co Inc A H	1-substituted-3-amido-pyrrolidines
GB1523631A (en)	1975-07-08	1978-09-06	Leo Pharm Prod Ltd	Sulphonamide derivatives
US4254135A (en)	1979-10-16	1981-03-03	A. H. Robins Company, Inc.	3-Amino-4-hydroxypyrrolidines
GB2295387A (en)	1994-11-23	1996-05-29	Glaxo Inc	Quinazoline antagonists of alpha 1c adrenergic receptors
SE9604786D0 (sv) *	1996-12-20	1996-12-20	Astra Pharma Inc	New compounds
EP1138672A1 (en)	1998-01-12	2001-10-04	Basilea Pharmaceutica AG	Process for the preparation of 3-amino-pyrrolidine derivatives
US6281243B1 (en) *	1998-02-26	2001-08-28	Akzo Nobel N.V.	Derivatives of azetidine and pyrrolidine
US7271176B2 (en) *	1998-09-04	2007-09-18	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use thereof
AU6589801A (en) *	2000-04-28	2001-11-12	F. Hoffmann-La Roche Ag	P-(sulfonyl)aryl and heteroaryls
NZ539828A (en)	2001-05-18	2007-01-26	Astrazeneca Ab	4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
EP1638934B1 (en) *	2003-06-11	2008-01-09	Eli Lilly And Company	3-aminopyrrolidines as inhibitors of monoamine uptake
BRPI0411594A (pt) *	2003-06-17	2006-08-29	Pfizer	derivados de n-pirrolidin-3-il-amida como inibidores de re-absorção de serotonina e noradrenalina
GB0314054D0 (en)	2003-06-17	2003-07-23	Pfizer Ltd	Amide derivatives as selective serotonin re-uptake inhibitors
EP1638560A1 (en)	2003-06-20	2006-03-29	Eli Lilly And Company	3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
TWI341835B (en)	2003-11-12	2011-05-11	Lg Life Sciences Ltd	Melanocortin receptor agonists
KR20060121178A (ko)	2003-12-12	2006-11-28	일라이 릴리 앤드 캄파니	일과성 전신 열감, 충동 조절 장애 및 일반적인 의학상태로 인한 인격 변화 치료용 선택적 노르에피네프린재흡수 억제제
EP1871762A2 (en)	2005-04-18	2008-01-02	Neurogen Corporation	Subtituted heteroaryl cb1 antagonists
TWI410406B (zh) *	2005-05-13	2013-10-01	Otsuka Pharma Co Ltd	吡咯烷化合物
WO2008000811A1 (en) *	2006-06-30	2008-01-03	Arcelik Anonim Sirketi	A cooling device

2006
- 2006-05-08 TW TW095116220A patent/TWI410406B/zh not_active IP Right Cessation
- 2006-05-08 TW TW102101997A patent/TWI439452B/zh not_active IP Right Cessation
- 2006-05-08 TW TW102143870A patent/TWI449692B/zh not_active IP Right Cessation
- 2006-05-11 MY MYPI20062198A patent/MY148653A/en unknown
- 2006-05-12 SI SI200631727T patent/SI2407451T1/sl unknown
- 2006-05-12 BR BRPI0610279-4A patent/BRPI0610279A2/pt not_active IP Right Cessation
- 2006-05-12 SG SG201003432-0A patent/SG162722A1/en unknown
- 2006-05-12 RU RU2007146512/04A patent/RU2414454C2/ru active
- 2006-05-12 CN CN201310516239.XA patent/CN103613587A/zh active Pending
- 2006-05-12 MX MX2007014252A patent/MX2007014252A/es active IP Right Grant
- 2006-05-12 ES ES06756356.9T patent/ES2451523T3/es not_active Expired - Lifetime
- 2006-05-12 IN IN758DEN2012 patent/IN2012DN00758A/en unknown
- 2006-05-12 WO PCT/JP2006/309988 patent/WO2006121218A1/en not_active Ceased
- 2006-05-12 EP EP11185205.9A patent/EP2407451B1/en not_active Expired - Lifetime
- 2006-05-12 ES ES11185205.9T patent/ES2446375T3/es not_active Expired - Lifetime
- 2006-05-12 EP EP06756356.9A patent/EP1881975B8/en not_active Expired - Lifetime
- 2006-05-12 DK DK11185205.9T patent/DK2407451T3/da active
- 2006-05-12 US US11/914,183 patent/US8084442B2/en not_active Expired - Fee Related
- 2006-05-12 AU AU2006244851A patent/AU2006244851B2/en not_active Ceased
- 2006-05-12 JP JP2007552427A patent/JP4776631B2/ja not_active Expired - Fee Related
- 2006-05-12 PT PT111852059T patent/PT2407451E/pt unknown
- 2006-05-12 KR KR1020077029022A patent/KR100971850B1/ko not_active Expired - Fee Related
- 2006-05-12 PL PL11185205T patent/PL2407451T3/pl unknown
- 2006-05-12 CN CN201310516326.5A patent/CN103613527B/zh not_active Expired - Fee Related
- 2006-05-12 KR KR1020107004207A patent/KR20100038453A/ko not_active Withdrawn
- 2006-05-12 AR ARP060101917A patent/AR054191A1/es unknown
- 2006-05-12 CN CNA2006800164024A patent/CN101175748A/zh active Pending
- 2006-05-12 CA CA2608184A patent/CA2608184C/en not_active Expired - Fee Related
2007
- 2007-11-09 ZA ZA200709691A patent/ZA200709691B/xx unknown
- 2007-11-12 IL IL187311A patent/IL187311A/en active IP Right Grant
2010
- 2010-05-14 AU AU2010201952A patent/AU2010201952A1/en not_active Abandoned
2011
- 2011-11-17 US US13/298,336 patent/US8420623B2/en not_active Expired - Fee Related
2013
- 2013-03-11 US US13/792,971 patent/US8815871B2/en not_active Expired - Fee Related
2014
- 2014-01-20 CY CY20141100049T patent/CY1114767T1/el unknown
- 2014-06-10 US US14/300,619 patent/US9611214B2/en not_active Expired - Fee Related
2017
- 2017-02-16 US US15/435,084 patent/US10000450B2/en not_active Expired - Fee Related
2018
- 2018-05-09 US US15/975,128 patent/US20180258038A1/en not_active Abandoned

Also Published As

Publication number	Publication date
KR20100038453A (ko)	2010-04-14
US20090088406A1 (en)	2009-04-02
AU2010201952A1 (en)	2010-06-10
EP2407451B1 (en)	2013-11-20
AU2006244851B2 (en)	2010-06-10
RU2007146512A (ru)	2009-06-20
TWI449692B (zh)	2014-08-21
ES2451523T8 (es)	2014-06-20
TW201319037A (zh)	2013-05-16
AU2006244851A1 (en)	2006-11-16
RU2010128620A (ru)	2012-01-20
CA2608184A1 (en)	2006-11-16
IL187311A0 (en)	2008-04-13
CN103613587A (zh)	2014-03-05
EP1881975B1 (en)	2014-01-08
WO2006121218A1 (en)	2006-11-16
TWI439452B (zh)	2014-06-01
JP2008540329A (ja)	2008-11-20
BRPI0610279A2 (pt)	2010-06-08
CA2608184C (en)	2013-09-24
US8084442B2 (en)	2011-12-27
ES2446375T3 (es)	2014-03-07
US20120065162A1 (en)	2012-03-15
IL187311A (en)	2012-08-30
US8815871B2 (en)	2014-08-26
JP4776631B2 (ja)	2011-09-21
TWI410406B (zh)	2013-10-01
ZA200709691B (en)	2009-09-30
US9611214B2 (en)	2017-04-04
KR100971850B1 (ko)	2010-07-22
EP1881975B8 (en)	2014-04-09
EP2407451A1 (en)	2012-01-18
PT2407451E (pt)	2014-01-13
TW201412708A (zh)	2014-04-01
CY1114767T1 (el)	2016-12-14
CN101175748A (zh)	2008-05-07
US20170166524A1 (en)	2017-06-15
US20180258038A1 (en)	2018-09-13
RU2414454C2 (ru)	2011-03-20
US8420623B2 (en)	2013-04-16
SG162722A1 (en)	2010-07-29
AR054191A1 (es)	2007-06-06
ES2451523T3 (es)	2014-03-27
PL2407451T3 (pl)	2014-04-30
US20130203750A1 (en)	2013-08-08
EP1881975A1 (en)	2008-01-30
TW200720249A (en)	2007-06-01
MY148653A (en)	2013-05-15
HK1193094A1 (zh)	2014-09-12
MX2007014252A (es)	2008-01-22
DK2407451T3 (da)	2013-12-16
CN103613527A (zh)	2014-03-05
US10000450B2 (en)	2018-06-19
SI2407451T1 (sl)	2014-02-28
KR20080008423A (ko)	2008-01-23
CN103613527B (zh)	2016-02-24
US20140288065A1 (en)	2014-09-25

Publication	Publication Date	Title
CY1108409T1 (el)	2014-02-12	Υβριδικα αντιβιοτικα οξαζολιδινονης-κινολονης
NO20062950L (no)	2006-08-23	5,7-diaminopyrazolo `43-Dlpyrimidiner med PDE-5 inhiberende aktivitet
TW200716558A (en)	2007-05-01	Heteroaroyl-substituted serineamides
TW200626610A (en)	2006-08-01	Analogs of 17-hydroxywortmannin as PI3K inhibitors
DK1432705T3 (da)	2007-09-17	Antibiotika med dobbeltvirkning
TW200716519A (en)	2007-05-01	Benzoyl-substituted serineamides
TW200626559A (en)	2006-08-01	Anilino-pyrimidine analogs
EA200702670A1 (ru)	2008-04-28	Препарат тиенопиридинового ингибитора агрегации тромбоцитов
TW200602322A (en)	2006-01-16	Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
HRP20050516B1 (hr)	2013-11-08	N-alkil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi
DK1613304T3 (da)	2008-01-21	DPP-IV-inhibitorer
SG170049A1 (en)	2011-04-29	Novel 11 beta - hydroxyandrosta-4-ene-3-ones
TW200745028A (en)	2007-12-16	Novel sulphonylpyrroles
EA200801608A1 (ru)	2008-10-30	Производные бензимидазолонкарбоновой кислоты
BR0313917A (pt)	2005-07-05	Composições antimicrobianas
TW200745027A (en)	2007-12-16	Novel sulphonylpyrroles
MXPA05013751A (es)	2006-03-08	Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales.
EA200801365A1 (ru)	2008-10-30	Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
EA200601106A1 (ru)	2006-12-29	Трициклические имидазопиридины для применения в качестве ингибиторов желудочной секреции
TW200801011A (en)	2008-01-01	New compounds II
GB0103046D0 (en)	2001-03-21	Organic Compounds
TW200621727A (en)	2006-07-01	Compounds and compositions useful as cathepsin s inhibitors
DK1648906T3 (da)	2008-02-04	Organo-silicium-forbindelser og deres anvendelse
TW200745053A (en)	2007-12-16	9-Aminocarbonylsubstituted derivatives of glycylcyclines
GB0314299D0 (en)	2003-07-23	Chemical compounds